Affordable Access

deepdyve-link
Publisher Website

Targeted deletion of somatotroph insulin-like growth factor-I signaling in a cell-specific knockout mouse model.

Authors
  • Romero, Christopher J
  • Ng, Yewade
  • Luque, Raul M
  • Kineman, Rhonda D
  • Koch, Linda
  • Bruning, Jens C
  • Radovick, Sally
Type
Published Article
Journal
Molecular Endocrinology
Publisher
The Endocrine Society
Publication Date
May 01, 2010
Volume
24
Issue
5
Pages
1077–1089
Identifiers
DOI: 10.1210/me.2009-0393
PMID: 20211984
Source
Medline
License
Unknown

Abstract

The role of IGF-I in the negative regulation of GH expression and release is demonstrated by in vitro and in vivo models; however, the targets and mechanisms of IGF-I remain unclear. We have developed a cell-specific knockout mouse in which the IGF-I receptor was ablated from the somatotroph in order to validate and characterize IGF-I negative regulation; we termed this the somatotroph IGF-I receptor knockout (SIGFRKO) mouse. The SIGFRKO mice demonstrated increased GH gene expression and secretion as well as increased serum IGF-I. Compensatory changes were noted with decreased GHRH and increased somatostatin mRNA expression levels. SIGFRKO mice had normal linear growth, but by 14 wk of age weighed significantly less than controls. Furthermore, metabolic studies revealed SIGFRKO mice had significantly less fat mass and body percent fat. These data support somatotroph IGF-I negative regulation and suggest that hypothalamic feedback limits the extent of GH release. The SIGFRKO mouse is a model delineating the mechanisms of IGF-I regulation in the hypothalamic-pituitary axis and demonstrates compensatory mechanisms that mediate growth and metabolic function in mammals.

Report this publication

Statistics

Seen <100 times